Montelukast, an asthma drug, can bind to and block a crucial SARS-CoV-2 protein. This discovery sets the stage for a new class of antiviral drugs, designed to target and interfere with the virus’ immunosuppressive tactics.
Asthma Medication Points The Way To Drugs To Prevent And Treat Covid-19: Nsp1, A Novel Target
